77747865 - FARM TO PHARM

Information

• Trademark
• 77747865

• Source

• Serial Number

  77747865

• International Classifications

  • 3 - Bleaching preparations and other substances for laundry use
  • 4 - Industrial oils and greases
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  May 29, 2009
  15 years ago

• Transaction Date

  March 13, 2014
  10 years ago

• Status Date

  March 13, 2014
  10 years ago

• Location Date

  March 13, 2014
  10 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  FRAZIER, TAMARA G

• Attorney Docket Number

  SWA0317TUS

  Attorney Name

  George A. Pelletier, Jr.

  Law Office Assigned Location Code

  M70

• Owners

  • PURGENESIS TECHNOLOGIES INC

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• GS0031: hair care products, namely, shampoo, hair shampoo concentrate, conditions, conditioner shampoo, neutralizer shampoo, re-hydrating shampoo, conditioner and hair dressing, hair color, hair dye, hair highlights, hair frost, hair bleach, peroxide, hair rinse and setting preparation, instant hair conditioner, hair spray, hair finisher, hair relaxer, hair straightening preparation, anti-frizz preparation, hair permanent waving and curling preparation, preparation for increasing hair body, rinse for controlling, preventing and treating dandruff, sun lotion and sun screen preparation for the hair, preparation for after sun care of the hair, hair styling gel, hair mask, hair wax, mustache wax, hair setting lotion, hair moisturizing lotion, hair oil, shaving soap, shaving cream, shaving gel, shaving balm, electric shaving lotion, after shave lotion, hair affixing tape and strips, spirit gum, hair piece remover, hair piece cleaner, permanent wave kits containing relaxer, neutralizing shampoo and hair setting lotion and gloves for use in applying the contents of the kit, and kits for the hair consisting of relaxer, conditioners, protective gel for the scalp, hair dressing and gloves for use in applying the contents of the kit; cosmetic products, namely, nail polish, nail varnish, nail polish remover, nail conditioner, emery paper; pumice stone; cosmetic dyes,anti-aging creams and serums, suntan lotion, suntan oil, sun screen, sun block, after sun lotion, colorants for the face, skin tanning lotion and cream, skin tanning spray, depilatories; lipstick, lip gloss, lip balm, lip sun screen, eye liner, mascara, eye shadow, eye brow pencil, face powder, foundation liquid and cream, liquid make up, powder make up, liquid blush, powder blush, make up removing preparations, make up compacts with puff with and without make up contents, blusher compacts with brush and with and without blusher contents, lipstick and lip gloss compacts with applicator and with and without lipstick or lip gloss, cotton swabs, cotton balls, exfoliant pads and cloths, tooth gel, tooth paste, tooth polish, tooth powder, tooth whitener and bleach; and mouth wash; body care products, namely, essential oil, massage oil, cleansing lotion and cleansing oil, astringents, night cream, anti-wrinkle cream and lotion, barrier cream, body cream and mud, mask preparation for treating the skin, bath salts, bubble bath, bath foam, bath oil, bath and shower gel, liquid and bar soap for personal use, body scrub and exfoliant; shaving soap, antiperspirant, talcum powder, body powder, perfume, eau de cologne, deodorant for personal use, perfuming sachets
• GS0041: biofuels, namely, gaseous, solid and liquid fuel derived from plant and other biomass material
• GS0051: pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, and tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; and nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; extended release formulations, compositions and agents for use in the manufacture of human and veterinary medicinal products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release pharmaceuticals for the treatment of angina and hypertension; rapidly dissolving matrix preparations for the delivery of medicinal active ingredients for the treatment of humans and for veterinary use botanical preparations and substances for the prevention, treatment and alleviation of stress; botanical preparations and substances for the prevention, treatment and alleviation of diabetes; botanical preparations and substances for the prevention, treatment and alleviation of hypertension; botanical preparations and substances for the prevention, treatment and alleviation of angina; botanical preparations and substances for the cessation of smoking; botanical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; botanical preparations and substances for the prevention, treatment and alleviation of herpes; botanical preparations and substances for the prevention, treatment and alleviation central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; botanical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; botanical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; botanical preparations and substances for the prevention, treatment and alleviation of depression; botanical based anti-depressants; botanical preparations and substances for the prevention, treatment and alleviation of sleep disorders; botanical preparations and substances for the prevention, treatment and alleviation of anxiety; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; botanical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; botanical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; botanical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; botanical preparations and substances, namely, fibrinolytic or thrombolytic agents; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; botanical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; botanical preparations and substances for the preventions treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; botanical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; botanical preparations and substances for the prevention, treatment and alleviation of migraines; botanical preparations and substances, namely, botanical skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; botanical preparations and substances for use in oncology; botanical preparations and substances for use in ophthalmology; and botanical based nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; botanical preparations and substance delivery platforms for controlling the solubility, compressibility and/or flowability of botanical preparations and substances; extended release formulations, compositions, and agents for use in the manufacture of human and veterinary botanical products for the treatment of circulatory, respiratory, endocrine, neurologic, cardio vascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic gastrointestinal, bone, sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release botanical preparations formulations, compositions and agents for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release botanical preparations and substances for the treatment of angina and hypertension; rapidly dissolving matrix preparations for the delivery of botanical active ingredients for the treatment of humans and for veterinary use biosensors for the identification and determination of concentration of substances and other parameters of biological interest; cosmeceutical products, namely, general and advanced hair care, cosmetic, tooth and mouth care, body care, anti-aging and anti-oxidant product lines that have medicinal or drug-like benefits; medical devices, namely, medical instruments for human and veterinary use
• GS0101: drug delivery platforms for controlling the solubility, compressibility and/or flowability of drugs; extended release formulations, compositions and agents for use in the manufacture of human and veterinary medicinal products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; implantable and extra-corporeal medical devices for human and veterinary non-invasive or surgical repair, fixation, support, immobilization or stabilization of trauma, fractures, disease, disorders, conditions and ailments; prostheses for human and veterinary use
• GS0161: paper towels, facial tissues; printed matter, namely, product monographs, training materials, conference programs, newsletters, brochures, posters, banners, and reports, all relating to the fields of pharmaceuticals, botanical products, biosensors, advanced biofuels, cosmeceutical products, body care, hair care, cosmetics, tooth and mouth care products and medical services; registration, manufacture, and sales of general product lines and advanced pharmaceutical products in the field of pharmaceuticals to the order and specification of others; research and development in the field of pharmaceuticals; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of pharmaceutical compounds; registration, manufacture, and sales of general product lines and advanced botanical products in the field of botanical products to the order and specification of others; research and development in the field of botanical products; formulation development
• GS0401: registration, manufacture, and sales of general product lines and advanced biosensors in the field of biosensors to the order and specification of others
• GS0421: research and development in the field of biosensors; research and development in the field of biofuels
• GS0441: clinical evaluation and testing, regulatory registration and joint venture/licensing of botanical products; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of biosensors; registration, manufacture, and sales of general product lines and advanced biofuels in the field of biofuels to the order and specification of others; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of biofuels; registration, manufacture and sales of general product lines and advanced cosmeceutical products in the field of cosmeceutical products to the order and specification of others; research and development in the field of cosmeceutical products; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of cosmeceutical products; registration, manufacture and sales of general product lines and advanced hair care, cosmetic, tooth and mouth care and body care products in the field of hair care, cosmetic, tooth and mouth care and body care products to the order and specification of others; research and development in the field of hair care, cosmetic, tooth and mouth care and body care products; registration, manufacture, and sales of general product lines and advanced medical devices in the field of medical devices to the order and specification of others; research and development in the field of medical devices; formulation development, clinical evaluation and testing, regulatory registration and joint venture/licensing of medical devices
• PM0000: FARM TO PHARMACEUTICAL

Case File Event Statements

• 3/13/2014 - 10 years ago

  50 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 3/13/2014 - 10 years ago

  49 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 8/2/2013 - 11 years ago

  48 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 8/2/2013 - 11 years ago

  47 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 8/2/2013 - 11 years ago

  46 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 7/30/2013 - 11 years ago

  45 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 1/28/2013 - 12 years ago

  44 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 1/28/2013 - 12 years ago

  43 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 1/28/2013 - 12 years ago

  42 - SUSPENSION LETTER WRITTEN Type: CNSL

• 1/22/2013 - 12 years ago

  41 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/22/2013 - 12 years ago

  40 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/22/2013 - 12 years ago

  39 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 1/9/2013 - 12 years ago

  38 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA

• 1/9/2013 - 12 years ago

  37 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP

• 1/9/2013 - 12 years ago

  36 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 7/10/2012 - 12 years ago

  35 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 7/10/2012 - 12 years ago

  34 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 7/10/2012 - 12 years ago

  33 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 6/29/2012 - 12 years ago

  32 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 6/1/2012 - 12 years ago

  31 - ASSIGNED TO EXAMINER Type: DOCK

• 12/27/2011 - 13 years ago

  30 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 12/27/2011 - 13 years ago

  29 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 12/27/2011 - 13 years ago

  28 - SUSPENSION LETTER WRITTEN Type: CNSL

• 12/7/2011 - 13 years ago

  27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/7/2011 - 13 years ago

  26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/21/2011 - 13 years ago

  25 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 5/20/2011 - 13 years ago

  24 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 5/20/2011 - 13 years ago

  23 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 5/20/2011 - 13 years ago

  22 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 4/28/2011 - 13 years ago

  21 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 4/28/2011 - 13 years ago

  20 - ASSIGNED TO LIE Type: ALIE

• 10/27/2010 - 14 years ago

  19 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 10/27/2010 - 14 years ago

  18 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 10/27/2010 - 14 years ago

  17 - SUSPENSION LETTER WRITTEN Type: CNSL

• 10/7/2010 - 14 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/6/2010 - 14 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/6/2010 - 14 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/6/2010 - 14 years ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/6/2010 - 14 years ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/6/2010 - 14 years ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/13/2010 - 14 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/13/2010 - 14 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/13/2010 - 14 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 3/1/2010 - 14 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/4/2009 - 15 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/4/2009 - 15 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/4/2009 - 15 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/28/2009 - 15 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/3/2009 - 15 years ago

  2 - NOTICE OF PSEUDO MARK MAILED Type: MPMK

• 6/2/2009 - 15 years ago

  1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS